Detection of Arg72Pro polymorphism of the tumor suppressor gene (TP53) by a rapid one-step tetra-primer amplification refractory mutation system-PCR

American Journal of Biochemistry and Molecular Biology

Volumn 1, Issue 2, 2011, Pages 231-236

  Lajin, Bassam ^a   Alachkar, Amal ^a  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

Human polymorphism; Polymerase chain reaction; RFLP; Rsl042522; Single nucleotide polymorphism; Tumor protein p53

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AMINO ACID ANALYSIS; AMPLICON; ARTICLE; CODON; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYRIAN ARAB REPUBLIC; TETRAPRIMER AMPLIFICATION REFRACTORY MUTATION SYSTEM POLYMERASE CHAIN REACTION;

TETRA;

EID: 79952023490     PISSN: 21504210     EISSN: 21504253     Source Type: Journal    
DOI: 10.3923/ajbmb.2011.231.236     Document Type: Article

References (20)

1. Agorastos, T., S. Masouridou, A.F. Lambropoulos, S. Chrisafi and D. Miliaras et al., 2004. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur. J. Cancer Prev., 13: 277-280.
2. Belyavskaya, V.A., V.K. Vardosanidze, O.Y. Smirnova, E.I. Karakin and I.V. Sav-kin et al., 2006. Genetic status of p53 in stomach cancer: Somatic mutations and polymorphism of codon 72. Bull. Exp. Biol. Med, 141: 243-246.
3. Chen, W.C, F.J. Tsai, J.Y. Wu, H.C. Wu, H.F. Lu and C.W. Li, 2000. Distributions of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumour. Urol. Res, 28: 293-296.
4. Costa, S, D. Pinto, D. Pereira, H. Rodrigues and J. Cameselle-Teijeiro et al., 2008. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer, 8: 32-32.
5. El-Deiry, W.S., 2003. The role of p53 in chemosensitivity and radiosensitivity. Oncogene, 22: 7486-7495.
6. Fisher, D.E, 2001. The p53 tumor suppressor: Critical regulator of life and death in cancer. Apoptosis, 6: 7-15.
7. Lee, J.M, Y.C. Lee, S.Y. Yang, W.L. Shi, C.J. Lee and S.P. Luh, 2000. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int. J. Cancer, 89: 458-464.
8. Levine, A.J, 1997. P53, The cellular gatekeeper for growth and division. Cell, 88: 323-331.
9. Malkm, D, 2001. The role of P53 in human cancer. J. Neuro-Oncol, 51: 231-243.
10. Matlashewski, G, P. Lamb, D. Pirn, J. Peacock, L. Crawford and S. Benchimol,1984 Isolation and characterization of a human p53 cDNA clone: Expression of the human p53 gene. EMBO J, 3:3257-3262
11. Noma, C, Y. Miyoshi, T. Tetsuya, T. Yasuhiro and N. Shinzaburo, 2004. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Lett, 210: 197-203.
12. Olivier, M, P. Hainaut and A.L. Borresen-Dale, 2005. Prognostic and Predictive Value of TP53 Mutations in Human Cancer. In: 25 Years of p53 Research Hainaut, P. and K.G. Wiman, Springer-Verlag, Netherlands.
13. Olivier, M, A. Petitjean, V. Marcel, A. Petre and M. Mounawar et al., 2009. Recent advances in p53 research: An interdisciplinary perspective. Cancer Gene Ther, 16: 1-12.
14. Perfumo, C, L. Bonelli, P. Menichini, A. Inga and V. Gismondi, 2006. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype. Digestion, 74: 228-235.
15. Petitjean, A, M.I.W. Achatz, A.L. Borresen-Dale, P. Hainaut and M. Olivier, 2007a. TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene, 26: 2157-2165.
16. Petitjean, A., E. Mathe, S. Kato, C. Ishioka and S.V. Tavtigian et al., 2007b. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Human Mutat., 28: 622-629.
17. Pietsch, E.C., O. Humbey and M.E. Murphy, 2006. Polymorphisms in the p53 pathway. Oncogene, 25: 1602-1611.
18. Thomas, M., A. Kalita, S.Labrecque, D. Pirn, L.Banks and G.Matlashewski, 1999. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell. Biol., 19: 1092-1100.
19. Weston, A., L.S. Perrm, K. Forrester, R.N. Hoover, B.F. Trump and C.C. Harris, 1992. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol. Biomarkers Prev., 1: 481-483.
20. Zehbe, I., G. Voglino, E. Wilander, H. Delius and A. Marongiu et al., 2001. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res., 61: 608-611.